Acute ischemic heart disease. Acute ischemic heart disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: : Vitamin D 3, 300,000 units
one dose
muscular. Intervention 2: Control group: Sterile water ampule
1mililiter
muscular.
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 84 Years
Inclusion criteria
Inclusion criteria: All patients who have been recently treated with atorvastatin
Exclusion criteria
Exclusion criteria: Previous history of statin use Previous history of Vitamin D Supplement use having musculoscletal symptoms history of musculoscletal disease history of thyroid disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Statin associated muscle symptom score. Timepoint: At the beginning of the study, 1, 2 and 3 months after the start of taking statin and administering vitamin D and placebo. Method of measurement: Statin associated Muscle Symptom Score Questionnaire.;Serum Creatine Kinase level. Timepoint: At the beginning of the study and 3 months later. Method of measurement: By the laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cholesterol. Timepoint: At the beginning of the study and 3 months later. Method of measurement: By the laboratory.;Fasting blood sugar. Timepoint: At the beginning of the study and 3 months later. Method of measurement: By the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Kabiri Rad
Mashhad University of Medical Sciences
Outcome results
None listed